| Literature DB >> 29423247 |
Songkiat Thanacharoenpanich1, Matthew J Boyle2, Robert F Murphy3, Patricia E Miller4, Michael B Millis4, Young-Jo Kim4, Yi-Meng Yen4.
Abstract
Patients with developmental dysplasia of the hip (DDH) who undergo periacetabular osteotomy (PAO) often have labral tears. The objective of this retrospective study was to compare PAO alone with PAO combined with arthrotomy or arthroscopy in DDH patients who had a full-thickness labral tear on magnetic resonance imaging. In total, 47 hips in the PAO group (PAO) were compared with 60 hips in the PAO with concomitant arthrotomy or arthroscopy (PAO-A) with respect to Hip Disability and Osteoarthritis Outcome Score (HOOS), modified Harris Hip Score (mHHS), Visual Analog Scale (VAS), clinical and radiographic outcomes at a median of 29 months. Reoperation rate and complications were compared between two groups of treatment. The PAO group was younger than the PAO-A group (25.2 ± 9.7 versus 31.3 ± 8.3). The PAO group was more likely to have worse dysplasia: lateral center edge angle (7.6°±9.63° versus 10.8°±6.85°) and anterior center edge angle (4°±12.92° versus 10.8°±9.92°). The PAO group had a higher preoperative mHHS (65.2 ± 15.3 versus 57.8 ± 14.8) and HOOS (66.3 ± 17.5 versus 55.8 ± 20.1). There were no significant differences in final functional outcome scores across treatment groups: mHHS (PAO; 86.8 ± 12.4 versus PAO-A, 83.3 ± 17.2), HOOS (86.5 ± 13.3 versus 82.5 ± 16.8) and VAS (2.5 ± 2.8 versus 2.5 ± 3.1). There was no difference in reoperation rate between two groups (6.4% versus 11.6%, P = 0.51). The overall complication rate was lower in the PAO group (26% versus 68%), but major complications were comparable. On the basis of our data, we were not able to conclusively demonstrate a clear benefit for the routine treatment of all labral tears; however, arthrotomy or arthroscopy may play a role in some conditions.Entities:
Year: 2018 PMID: 29423247 PMCID: PMC5798119 DOI: 10.1093/jhps/hnx048
Source DB: PubMed Journal: J Hip Preserv Surg ISSN: 2054-8397
Baseline characteristics across treatment groups for the entire cohort (N = 107)
| PAO | PAO-A | ||||
|---|---|---|---|---|---|
| (n = 47) | (n = 60) | ||||
| Variable | Mean | ±SD | Mean | ±SD | P |
| Age (years) | 25.2 | ± 9.65 | 31.3 | ± 8.63 | 0.001 |
| Sex (% male) | 6 | (13%) | 5 | (8%) | 0.46 |
| BMI | 24.8 | ± 4.37 | 25 | ± 4.19 | 0.77 |
| Side (% right) | 23 | (49%) | 29 | (48%) | 0.95 |
| Duration of symptoms [months; median (IQR)] | 36 | (10–56) | 36 | (18–61) | 0.20 |
| Mechanical symptoms (% yes) | 28 | (60%) | 40 | (67%) | 0.45 |
| Chondromalacia on MRI (% yes) | 30 | (64%) | 43 | (72%) | 0.39 |
| Anterior impingement sign (% positive) | 36 | (77%) | 56 | (93%) | 0.02 |
| Posterior impingement sign (% positive) | 0 | (0%) | 3 | (5%) | 0.99 |
| Trendelenburg gait (% abnormal) | 16 | (34%) | 20 | (33%) | 0.94 |
| Trendelenburg’s sign (% positive) | 18 | (38%) | 31 | (52%) | 0.17 |
| LCEA | 7.6 | ± 9.63 | 10.8 | ± 6.85 | 0.05 |
| ACEA | 4 | ± 12.92 | 10.8 | ± 9.92 | 0.005 |
| Tonnis angle | 23 | ± 6.47 | 21.4 | ± 6.43 | 0.21 |
| Alpha angle | 49.2 | ± 7.13 | 60 | ± 11.23 | <0.001 |
| Joint space width (mm) | 4.4 | ± 1.11 | 4.3 | ± 0.67 | 0.50 |
| Joint congruency | |||||
| Excellent | 23 | (49%) | 42 | (70%) | 0.04 |
| Good | 1 | (2%) | 2 | (3%) | |
| Fair | 2 | (4%) | 16 | (27%) | |
| Tonnis grade | |||||
| 0 | 24 | (51%) | 20 | (33%) | 0.22 |
| 1 | 18 | (38%) | 38 | (63%) | |
| 2 | 5 | (11%) | 2 | (3%) | |
| Pain | 6.1 | ± 3.07 | 6.6 | ± 2.62 | 0.41 |
| mHHS | 65.2 | ± 15.32 | 57.8 | ± 14.77 | 0.02 |
| HOOS total score | 66.3 | ± 17.52 | 55.8 | ± 20.06 | 0.008 |
| Symptoms | 66.6 | ± 17.45 | 53.1 | ± 21.22 | 0.002 |
| Pain | 62.8 | ± 20.30 | 53.4 | ± 21.11 | 0.03 |
| Function | 75.6 | ± 18.91 | 66.6 | ± 23.13 | 0.04 |
| Sports | 52.4 | ± 24.47 | 36.8 | ± 26.22 | 0.003 |
| Quality of life | 40.2 | ± 21.32 | 28.4 | ± 18.10 | 0.004 |
Change in radiographic measurements from preoperative to postoperative by treatment group
| Preoperative | Postoperative | Change | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAO only | PAO-A | PAO only | PAO-A | PAO only | PAO-A | ||||||||
| Mean | ±SD | Mean | ±SD | Mean | ±SD | Mean | ±SD | Mean | ±SD | Mean | ±SD | P | |
| LCEA | 7.6 | ± 9.63 | 10.8 | ± 6.85 | 30.1 | ± 5.97 | 28.3 | ± 4.84 | 22.5 | ± 8.25 | 17.5 | ± 6.56 | 0.002 |
| ACEA | 4 | ± 12.92 | 10.8 | ± 9.92 | 28.6 | ± 7.45 | 28.8 | ± 6.03 | 24.9 | ± 11.19 | 18.1 | ± 8.50 | 0.002 |
| Tonnis angle | 23 | ± 6.47 | 21.4 | ± 6.43 | 6.3 | ± 4.08 | 7 | ± 3.97 | ± 5.57 | −14.4 | ± 5.72 | 0.04 | |
| AA | 49.2 | ± 7.13 | 60 | ± 11.23 | 47.9 | ± 5.39 | 50.3 | ± 7.34 | −1.3 | ± 4.91 | −9.4 | ± 10.50 | <0.001 |
| JSW | 4.4 | ± 1.11 | 4.3 | ± 0.67 | 3.7 | ± 0.81 | 3.9 | ± 0.60 | −0.6 | ± 0.86 | −0.3 | ± 0.68 | 0.04 |
| Freq. | (%) | Freq. | (%) | Freq. | (%) | Freq. | (%) | Freq. | (%) | Freq. | (%) | P | |
| Joint congruency | |||||||||||||
| Excellent | 23 | (49) | 42 | (70) | 35 | (74) | 53 | (88) | 12 | (26) | 11 | (18) | 0.75 |
| Good | 1 | (2) | 2 | (3) | 5 | (11) | 0 | (0) | 4 | (9) | −2 | (−3) | |
| Fair | 2 | (4) | 16 | (27) | 6 | (13) | 7 | (12) | 4 | (9) | −9 | (−15) | |
| Tonnis grade | |||||||||||||
| 0 | 24 | (51) | 20 | (33) | 18 | (38) | 17 | (28) | −6 | (−13) | −3 | (−5) | 0.46 |
| 1 | 18 | (38) | 38 | (63) | 23 | (49) | 38 | (63) | 5 | (11) | 0 | (0) | |
| 2 | 5 | (11) | 2 | (3) | 6 | (13) | 5 | (8) | 1 | (2) | 3 | (5) | |
P-values are result of the comparison of the change in measurement across treatment groups.
Final measurements and outcomes at final follow-up
| PAO (n = 47) | PAO-A (n = 60) | ||||
|---|---|---|---|---|---|
| Variable | Mean | ± SD | Mean | ± SD | P |
| Pain | 2.5 | ± 2.81 | 2.5 | ± 3.12 | 0.94 |
| mHHS | 86.8 | ± 12.42 | 83.3 | ± 17.23 | 0.24 |
| HOOS total score | 86.5 | ± 13.28 | 82.5 | ± 16.78 | 0.19 |
| Symptoms | 78.2 | ± 18.55 | 75.2 | ± 15.66 | 0.37 |
| Pain | 85.9 | ± 15.31 | 83.7 | ± 18.06 | 0.51 |
| Function | 92.5 | ± 11.78 | 89.4 | ± 15.71 | 0.27 |
| Sports | 77.9 | ± 21.41 | 71 | ± 23.47 | 0.12 |
| Quality of life | 72.6 | ± 18.50 | 64.4 | ± 25.06 | 0.07 |
| Duration of follow-up [months; median (IQR)] | 25 | (13–37) | 31 | (16–54) | 0.21 |
Change in outcome scores from preoperative to final follow-up across treatment groups
| Outcome | PAO (n = 47) | PAO-A (n = 60) | ||||
|---|---|---|---|---|---|---|
| Mean difference | 95% CI | Mean difference | 95% CI | Unadjusted | Adjusted | |
| Pain | −3.7 | (−4.89, −2.32) | −4.1 | (−5.19, −3.06) | 0.38 | 0.32 |
| mHHS | 21.6 | (15.88, 27.32) | 24.8 | (19.61, 31.27) | 0.64 | 0.58 |
| HOOS total score | 20.2 | (13.84, 26.58) | 26.7 | (20.02, 33.40) | 0.22 | 0.55 |
| Symptoms | 11.6 | (4.22, 18.97) | 22.2 | (15.42, 28.91) | 0.08 | 0.20 |
| Pain | 23.1 | (15.71, 30.46) | 30.3 | (23.15, 37.35) | 0.44 | 0.98 |
| Function | 16.9 | (10.43, 23.37) | 22.7 | (15.59, 29.91) | 0.11 | 0.48 |
| Sports | 25.5 | (16.11, 34.95) | 34.3 | (25.27, 43.27) | 0.49 | 0.78 |
| Quality of life | 32.4 | (24.26, 40.62) | 35.9 | (28.03, 43.85) | 0.52 | 0.31 |
Adjusted P-values are based on multivariable regression models controlling for baseline covariates.
Change in outcome scores from preoperative to final follow-up across three treatment subgroups
| PAO only (n = 47) | PAO ± arthrotomy (n = 42) | PAO ± arthroscopy (n = 17) | ||||||
|---|---|---|---|---|---|---|---|---|
| Outcome | Mean difference | 95% CI | Mean difference | 95% CI | Mean difference | 95% CI | Unadjusted | Adjusted |
| P-value | P-value | |||||||
| Pain | −3.7 | (−4.92, −2.38) | −4.2 | (−5.55, −2.8) | −3.9 | (−5.62, −2.26) | 0.77 | 0.66 |
| mHHS | 21.5 | (15.6, 27.3) | 26.8 | (19.48, 34.03) | 22.8 | (13.19, 32.46) | 0.46 | 0.41 |
| HOOS total score | 20.4 | (13.71, 27.09) | 26.9 | (18.6, 35.15) | 26.2 | (15.18, 37.14) | 0.06 | 0.13 |
| Symptoms | 12.2 | (4.75, 19.63) | 20.8 | (12.39, 29.27) | 24.4 | (12.54, 36.28) | 0.03 | 0.08 |
| Pain | 23.3 | (15.77, 30.8) | 30.6 | (21.93, 39.26) | 29.3 | (16.33, 42.2) | 0.14 | 0.31 |
| Function | 17.0 | (10.09, 23.98) | 23.2 | (14.19, 32.1) | 21.7 | (11.39, 32.04) | 0.04 | 0.12 |
| Sports | 25.9 | (16.33, 35.49) | 33.6 | (22.73, 44.53) | 35.3 | (18.35, 52.24) | 0.65 | 0.36 |
| Quality of life | 32.6 | (24.24, 40.85) | 35.9 | (26.18, 45.54) | 36.0 | (21.8, 50.26) | 0.20 | 0.11 |
Adjusted P-values are based on multivariable regression models controlling for baseline covariates.
Complications by treatment group according to modified Dindo–Clavien system
| PAO = 47, | PAO-A = 60, | |
|---|---|---|
| Grade 1 | ||
| HO (Grade 1, or 2) | 7 (15) | 28 (47) |
| Spinal headache | 0 (0) | 1 (2) |
| Broken and retained Instrument | 0 (0) | 1 (2) |
| Grade 2 | ||
| LFCN dysesthesia | 2 (4) | 8 (13) |
| Peroneal nerve neurapraxia | 1 (2) | 3 (5) |
| Delayed union pubic rami (minimal symptom) | 1 (2) | 0 (0) |
| Non-union ischial stress fracture (minimal symptom) | 0 (0) | 1 (2) |
| Wound complication (central wound breakage, stitch abscess) | 0 (0) | 2 (3) |
| Grade 3 | ||
| HO (Grade 3 requiring excision) | 0 (0) | 1 (2) |
| Wound hematoma (requiring incision and drainage) | 1 (2) | 0 (0) |
| Undercoverage (requiring revision PAO) | 1 (2) | 1 (2) |
| Grade 4 | ||
| None |
Complications by treatment groups
| PAO | PAO-A | |||||||
|---|---|---|---|---|---|---|---|---|
| ( | ( | |||||||
| Variable | Mean | ± SD | Mean | ± SD | Unadjusted | Odds ratio | (95% CI) | |
| At least one complication | 12 | (26%) | 41 | (68%) | <0.001 | 0.001 | 5.3 | (1.89–14.92) |
| Complication grading | ||||||||
| 1 | 6 | (50%) | 25 | (61%) | 0.35 | 0.95 | ||
| 2 | 4 | (33%) | 14 | (34%) | ||||
| 3 | 2 | (17%) | 2 | (5%) | ||||
| 4 | 0 | (0%) | 0 | (0%) | ||||
Odds ratios were estimated from adjusted analysis.
Adjusted P-values are based on multivariable regression models controlling for baseline covariates.